Differential indication of lipoprotein apheresis during pregnancy

Therapeutic Apheresis

Volumn 7, Issue 3, 2003, Pages 359-364

  Klingel, Reinhard ^a   Göhlen, Britta ^a   Schwarting, Andreas ^b   Himmelsbach, Frido ^c   Straube, Richard ^d  

^a Apheresis Research Institute   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^c Center for Dialysis and Apheresis   (Germany)

^d District Hospital Ludenscheid   (Germany)

Author keywords

Familial hypercholesterolemia; Lipid metabolism; Lipoprotein apheresis; Pancreatitis; Plasma exchange; Pregnancy

Indexed keywords

APHERESIS; ARTICLE; CHILDHOOD MORTALITY; FAMILIAL HYPERCHOLESTEROLEMIA; HYPERLIPOPROTEINEMIA; LIPID METABOLISM; LIPOPROTEIN APHERESIS; MATERNAL MORBIDITY; MATERNAL MORTALITY; PREGNANCY; PREGNANCY DISORDER; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

BLOOD COMPONENT REMOVAL; CHOLESTEROL, LDL; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; LIPID METABOLISM; LIPOPROTEINS, LDL; PLASMAPHERESIS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREGNANCY, HIGH-RISK; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0038487270     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-0968.2003.00066.x     Document Type: Article

References (50)

1. Watson WJ, Katz VL, Bowes WA. Plasmapheresis during pregnancy. Obstet Gynecol 1990;76:451-7.
2. Zeeman GG. A case of acute inflammatory demyelinating polyradiculoneuropathy in early pregnancy. Am J Perinetol 2001;18:213-5.
3. Wallace DJ. Apheresis for lupus erythematosus. Lupus 1999;8:174-80.
4. Richter WO. Die familiäre Hypercholesterinämie. Der Lipidreport 1995;1:5-14.
5. Krone W, Müller-Wieland D, Lipidstoff wechsel. In: Thiemes Innere Medizin-, TIM Stuttgart, New York: Thieme 1999, 322-34.
6. Thompson GR, Lowenthal R, Myant NB. Plasma exchange in the management of homozygous familial hypercholesterolaemia. Lancet 1975;31:1208-11.
7. Schamberger BM, Geiss HC, Ritter MM, Schwandt P, Parhofer KG. Influence of LDL apheresis on LDL subtypes in patients with coronary heart disease and severe hyperlipoproteinemia. J Lipid Res 2000;41:727-32.
8. Bundesausschusses der Ärzte und Krankenkassen. Ambulante Durchführung der LDL-Elimination als extrakorporales Verfahren. Deutsches Ärzteblatt 1998;95:A1930 (in German).
9. Bosch T, Geiss HC, Schwandt P, Schwandt, P, Richter, WO, Parhofer, KG. Handbuch der Fettstoffwechselstörungen. Stuttgart: Schattauer, 2001;571-4.
10. Parhofer KG, Geiss HC, Schwandt P. Efficacy of different low-density lipoprotein apheresis methods. Ther Apher 2000;4:382-5.
11. Dittrich E, Schmaldienst S, Langer M, Jansen M, Hörl WH, Derfler K. Immunoadsorption and Plasma Exchange in Pregnancy. Kidney Blood Press Res 2002;25:232-9.
12. Swoboda K, Derfler K, Koppensteiner R et al. Extracorporeal lipid elemination for treatment of gestational hyperlipidemic pancreatitis. Gastroenterol 1993;104:1527-31.
13. Kroon AA, Swinkels DW, van Dongen PWJ, Stalenhoef AFH. Pregnancy in a patient with homozygous familial hypercholesterolemia treated with long-term low-density lipoprotein apheresis. Metabolism 1994;43:1164-70.
14. Lin SY, Wang, YY, Shiao SW, Lin HD, Tsai ST. Gestational pancreatitis complicating uncontrolled diabetes mellitus. Postgraduate Med J 1999;75:241-3.
15. Schaumann D, Welch-Wichary M, Voss A, Schmidt H, Olbricht CJ. Prospective cross-over comparison of three low-density lipoprotein (LDL) -apheresis methods in patients with familial hypercholersterolemia. Eu J Clin Invest 1996;26:1033-8.
16. Richter WO, Donner MG, Schwandt P. Three low density lipoprotein apheresis techniques in treatment of patients with familial hypercholesterolemia: a long-term evaluation. Ther Apher 1999;3:203-8.
17. Kim HJ, Kalkhoff RK. Changes in lipoprotein composition during the menstrual cycle. Metabolism 1979;28:663-8.
18. Fåhraeus L, Larsson-Cohn U, Wallentin L. Plasma lipoproteins including high density lipoprotein subfractions during normal pregnancy. Obstetrics Gynecol 1985;66:468.
19. Potter JM, Nestel PJ. The hyperlipidemia of pregnancy in normal and complicated pregnancies. Am J Obstet Gynecol 1979;133:165-70.
20. Khaliq F, Singhal U, Arshad Z, Hossain MM. Study of serum lipid and lipoprotein in preeclampsia with special reference to parity. Ind J Physiol Pharmacol 2000;44:192-6.
21. Sattar N, Clark P, Greer IA, Shepherd J, Packard CJ. Lipoprotein (a) levels in normal pregnancy and in pregnancy complicated with pre-eclampsia. Atherosclerosis 2000;148:407-11.
22. Zechner R, Desoye G, Schweditsch MO, Pfeiffer KP, Kostner GM. Fluctations of plasma lipoprotein-a concentrations during pregnancy and post partum. Metabolism 1986;35:333-6.
23. Nies BM, Dreiss RJ. Hyperlipemic pancreatitis in pregnancy: a case report and review of the literature. Am J Perinatol 1990;7:166-9.
24. Aalders K, Huisman A, Bosker HA. Myocardinfarct in het kraambed. Ned Tijdschr Geneeskd 1998;142:1103-5.
25. Hameed AB, Padmini P, Goodwin TM. Unstable angina during pregnancy in two patients with premature coronary atherosclerosis and aortic stenosis in asscociation with familial hypercholesterolemia. Am J Obstet Gynecol 2000;182:1152-5.
26. Bircks W, Herzer JA. Operative Therapie kardiovaskulärer Erkrankungen und Schwangerschaft. In: Lau H, ed. Indikationen Zum Schwangerschaftsabbruch. Graefelfing: Detmer Verlag, 1982;70-6.
27. Palinski W, Napoli C. The fetal origins of atherosclerosis, maternal hypercholesterolemia, and cholesterol-lowering or antioxidant treatment during pregnancy influence in utero programming amd postnatal susceptibility to atherogenesis. FASEB J 2002;16:1348-60.
28. Cashin-Hemphill L, Noone M, Abbott J, Waksmonski CA, Lees R. Low-density lipoprotein apheresis therapy during pregnancy. Am J Cardiol 2000;86:1160.
29. Beigel Y, Bar J, Cohen M, Hod M. Pregnancy outcome in famial homozygous hypercholesterolemic females treated with long-term plasma exchange. Acta Obstet Gynecol Scand 1998;77:603-8.
30. Goldstein BL, Hofshire PJ, Sears TD, Rayburn WF. Long-term plasmapheresis in the homozygous hyperlipemic patient. Am Heart J 1991;122:1465-6.
31. Mora C, Teruel JL, Navarro JF. Low-density lipoprotein apheresis in homozygous familial hypercholesterolemia. Am J Cardiol 2001;88:202-3.
32. Lee RV, Rodgers BD, Young C, Eddy E, Cardinal J. Total parenteral nutrition during pregnancy. Obstet Gynecol 1986;68:563-71.
33. Achard JM, Wetseel PF, Moriniere P, Lalau J, de Cagny B, Fournier A. Pancreatitis related to severe acute hypertriglyceridemia during pregnancy treatment with lipoprotein apheresis. Intensive Care Med 1991;17:236-7.
34. Ahner R, Speiser P, Swoboda K et al. Hyperlipidämie induzierte Pankreatitis in der Schwangerschaft. Gynäkol Geburtshilf Rundsch 1993;33:337.
35. Bildirci I, Esinler I, Deren O, Durukan T, Kabay B, Onderoglu L. Hyperlipidemic pancreatitis during pregnancy. Acta Obstet Gynecol Scand 2002;81:468-70.
36. Lennertz A, Parhofer KG, Samtleben W, Bosch T. Therapeutic plasma exchange in patients with chylomicronemia syndrome complicated by acute pancreatitis. Ther Apher 1999;3:227-33.
37. Majlis S, Anguita T, Weishaupt R, Socias M. Plasmapheresis in acute pancreatitis secondary to famlial hyperlipidemia in a pregnant women. Revista Med Da Chile 1989;117:1275-8.
38. Heilmann L. Die Veränderungen der Fließeigenschaften des Blutes während der Schwangerschaft. Zent Bl Gynäkol 1986;108:393-402.
39. Ohlmann P, Jung F, Mrowietz C, Alt T, Schmidt W. Peripheral microcirculation during pregnancy and in woman with pregnacy induced hypertension. Clin Hemorheol Microcirculation 2001:24:183-91.
40. Pepple DJ, Reid HL, Mullings AM. Is there hyperviscosity in pre-eclampsia? West Indian Med J 2000;49:229-31.
41. Zendejas Cervantes LH, Romero RH, Lechuga Martin del Campo A. Preeclampsia-eclampsia: a change in utero-plancental microcirculation. Immunologic, histologic, and biochemical features. Rev Alerg Mex 2002;49:80-6.
42. Tamai O, Matsuoka H, Itabe H, Wada Y, Kohno K, Imaizumi T. Single LDL-apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans. Circulation 1997;95:76-82.
43. Julius U, Siegert G, Gromeier S. Intraindividual comparison of the impact of two selective apheresis methods (DALI and HELP) on the coagulation system. Int J Art Org 2000;3:199-206.
44. Hubel CA, McLaughlin MK, Evans RW, Hauth BA, Sims CJ, Roberts JM. Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48 hours post partum. Am J Obstet Gynecol 1996;174:975-82.
45. van Pampus MG, Koopman MMW, Wolf H, Büller HR, Prins MH, van der Ende A. Lipoprotein (a) concentrations in women with a history of severe preeclampsia - a case control study. Thromb Haemost 1998;82:10-3.
46. Thadhani R, Stampfer MJ, Hunter DJ, Manson JE, Solomon CG, Curhan GC. High body mass index and hypercholesterolemia: risk of hypertensive disorders of pregnancy? Am Coll Obst Gyn 1999;94:543-50.
47. Heilmann L, Rath W, Friedrich von Tempelhoff G et al. Niedermolekulare Heparine in der Schwangerschaft. Dt. Ärzteblatt 2002, 99/7: C320-C325.
48. Aijas A, Nelson J, Naseer N. Management of heparin allergy in pregnancy. Am J Hematol 2001;67:268-9.
49. Saravanan P, Blumenthal S, Anderson C, Stein R, Berkelhammer C. Plasmaexchange for dramatical gestational hyperlipidemic pancreatitis. J Clin Gastroenterol 1996;22:295-8.
50. Yamauchi H, Sunamura M, Takeda K, Suzuki T, Itoh K, Miyagawa K. Hyperlipidemia and pregnancy associated pancreatitis with reference to plasma exchange as a therapeutic intervention. Tohoku J Exp Med 1986;148:197-205.